Abstract PS09-09: Multiomics profiling and molecular classification refine precision treatment strategies for HER2-positive breast cancerYuwei Li, Zhi‐Ming Shao, Yi‐Zhou Jiang et al.|Cancer Research|2024Cited by 1
Data from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic StrategiesYu-Wei Li, Zhi‐Ming Shao, Lei-Jie Dai et al.|Unknown|2024Cited by 1
Table S1 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic StrategiesYu-Wei Li, Zhi‐Ming Shao, Lei-Jie Dai et al.|Unknown|2024Cited by 0
Figure S1 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic StrategiesYu-Wei Li, Zhi‐Ming Shao, Lei-Jie Dai et al.|Unknown|2024Cited by 0
Supplemental Materials and Methods from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic StrategiesYu-Wei Li, Zhi‐Ming Shao, Lei-Jie Dai et al.|Unknown|2024Cited by 0